Comparative Study of Prophylactic Antibiotic Twice a Week Versus Every Night in Recurrent Urinary Tract Infections in Children
Journal of Pediatric Nephrology,
Vol. 9 No. 3 (2021),
4 September 2021
,
Page 1-5
https://doi.org/10.22037/jpn.v9i3.34181
Abstract
Background and Aim: Urinary tract infection is one of the most common childhood diseases. The results of studies investigating discontinuation or continuation of antibiotics in children with recurrent urinary tract infections and urinary reflux are controversial. Therefore, this study was conducted to compare prophylactic antibiotic treatment twice a week versus every night in the recurrence of urinary tract infections in children.
Methods: This clinical trial was conducted using non-random simple sampling. Group A was given a single daily dose of cephalexin 10 mg/kg and group B was given cotrimoxazole at a dose of 5 mg/kg. Both groups were followed for ten months. Recurrences of urinary tract infections were compared between the two groups.
Results: The mean age of the participants was 3.53±2.04 years. Most of the subjects were female (n=37, 61.7%). Urinary reflux was unilateral in 65% of the cases (n=39) and bilateral in the rest. There was no significant difference in age distribution, sex, and type of reflux between groups A and B. The frequency of recurrent urinary tract infection was 8.3% in group A and 6.7% in group B indicating no significant difference (p = 0.500).
Conclusion: The results of this study showed that the frequency of recurrence of urinary tract infections in children who received prophylactic antibiotic treatment twice a week was not significantly different compared to the group of children who received continuous antibiotic prophylaxis.
- Urinary Tract Infection
- Antibiotic Prophylaxis
- Pediatrics
- Cotrimoxazole
How to Cite
References
Dias C, Silva J, Diniz J, Lima E, Marciano R, Lana L et al. Risk Factors for Recurrent Urinary Tract Infections in a Cohort of Patients With Primary Vesicoureteral Reflux. Pediatric Infectious Disease Journal. 2010;29(2):139-144.
Beetz R. May we go on with antibacterial prophylaxis for urinary tract infections?. Pediatric Nephrology. 2005;21(1):5-13.
Hellerstein S, Nickell E. Prophylactic antibiotics in children at risk for urinary tract infection. Pediatric Nephrology. 2002;17(7):506-510.
Palleschi G, Carbone A, Zanello P, Mele R, Leto A, Fuschi A et al. Prospective study to compare antibiosis versus the association of N-acetylcysteine, D-mannose and Morinda citrifolia fruit extract in preventing urinary tract infections in patients submitted to urodynamic investigation. Archivio Italiano di Urologia e Andrologia. 2017;89(1):45.
Alconcher L, Meneguzzi M, Buschiazzo R, Piaggio L. Could prophylactic antibiotics be stopped in patients with history of vesicoureteral reflux?. Journal of Pediatric Urology. 2009;5(5):383-388.
Bollgren I. Antibacterial prophylaxis in children with urinary tract infection. Acta Paediatrica. 2007;88:48-52.
Mattoo T. Are prophylactic antibiotics indicated after a urinary tract infection?. Current Opinion in Pediatrics. 2009;21(2):203-206.
Hayashi Y, Kojima Y, Kamisawa H, Imura M, Mizuno K, Kohri K. Is antibiotic prophylaxis effective in preventing urinary tract infections in patients with vesicoureteral reflux?. Expert Review of Anti-infective Therapy. 2010;8(1):51-58.
Thompson R, Chen J, Pugach J, Naseer S, Steinhardt G. Cessation of prophylactic antibiotics for managing persistent vesicoureteral reflux. Journal of Urology. 2001;166(4):1465-1469.
Kitchens D, Herndon A, Joseph D. Outcome After Discontinuing Prophylactic Antibiotics in Children With Persistent Vesicoureteral Reflux. Journal of Urology. 2010;184(4S):1594-1597.
Cheng C, Tsai M, Huang Y, Su L, Tsau Y, Lin C et al. Antibiotic Resistance Patterns of Community-Acquired Urinary Tract Infections in Children With Vesicoureteral Reflux Receiving Prophylactic Antibiotic Therapy. PEDIATRICS. 2008;122(6):1212-1217.
Weiss R, Duckett J, Spitzer A. Results of A Randomized Clinical Trial of Medical Versus Surgical Management of Infants and Children with Grades III and IV Primary Vesicoureteral Reflux (United States). Journal of Urology. 1992;148(5 Part 2):1667-1673.
Cooper C, Chung B, Kirsch A, Canning D, Snyder H. The outcome of stopping prophylactic antibiotics in older children with vesicoureteral reflux. The Journal of Urology. 2000;:269.
Ohata Y, Ohta H, Hashii Y, Tokimasa S, Ozono K, Hara J. Intermittent oral trimethoprim/sulfamethoxazole on two non-consecutive days per week is effective asPneumocystis jirovecipneumonia prophylaxis in pediatric patients receiving chemotherapy or hematopoietic stem cell transplantation. Pediatric Blood & Cancer. 2009;52(1):142-144.
Ono K, Tsujimura H, Sugawara T, Ise M, Satou A, Wang X et al. Twice-Weekly Trimethoprim-Sulfamethoxazole for the Prevention of Pneumocystis Jiroveci Pneumonia in Non-Hodgkin Lymphoma Patients. Blood. 2015;126(23):5093-5093.
Conway P, Cnaan A, Zaoutis T, Henry B, Grundmeier R, Keren R. Recurrent Urinary Tract Infections in Children. JAMA. 2007;298(2):179.
Brandström P, Jodal U, Sillén U, Hansson S. The Swedish reflux trial: Review of a randomized, controlled trial in children with dilating vesicoureteral reflux. Journal of Pediatric Urology. 2011;7(6):594-600.
Craig J, Simpson J, Williams G, Lowe A, Reynolds G, McTaggart S et al. Antibiotic Prophylaxis and Recurrent Urinary Tract Infection in Children. New England Journal of Medicine. 2009;361(18):1748-1759.
Roussey-Kesler G, Gadjos V, Idres N, Horen B, Ichay L, Leclair M et al. Antibiotic Prophylaxis for the Prevention of Recurrent Urinary Tract Infection in Children With Low Grade Vesicoureteral Reflux: Results From a Prospective Randomized Study. Journal of Urology. 2008;179(2):674-679.
- Abstract Viewed: 360 times
- PDF Downloaded: 251 times